These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2848561)

  • 21. Does the association dipyridamole-aspirin only act by a functional synergism?
    De la Cruz JP; Sanchez de la Cuesta F
    Gen Pharmacol; 1991; 22(2):271-4. PubMed ID: 2055420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.
    De La Cruz JP; Blanco E; Sánchez de la Cuesta F
    Eur J Pharmacol; 2000 May; 397(1):35-41. PubMed ID: 10844096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO; Humphrey WR; Aiken JW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2.
    Armstrong PC; Truss NJ; Ali FY; Dhanji AA; Vojnovic I; Zain ZN; Bishop-Bailey D; Paul-Clark MJ; Tucker AT; Mitchell JA; Warner TD
    J Thromb Haemost; 2008 Nov; 6(11):1933-43. PubMed ID: 18752570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
    Mehta J; Mehta P
    J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of collagen-induced platelet aggregation and release function by aspirin and dipyridamole in cynomolgus monkey].
    Wang ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Jun; 12(2):131-3. PubMed ID: 6489139
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
    Heptinstall S; Fox S; Crawford J; Hawkins M
    Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
    Caplain H
    Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
    Kuliopulos A; Mohanlal R; Covic L
    Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of dipyridamole.
    Harker LA; Kadatz RA
    Thromb Res Suppl; 1983; 4():39-46. PubMed ID: 6356465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of low-dose acetylsalicylic acid on platelet aggregation parameters in vitro].
    Cardona M; Escolar G; Roig E; Bastida E; Ordinas A; Sanz G
    Rev Esp Cardiol; 1992 Apr; 45(4):264-9. PubMed ID: 1598464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia: further studies of the effects of heparin-dependent antibodies on platelets.
    Chong BH; Castaldi PA
    Br J Haematol; 1986 Oct; 64(2):347-54. PubMed ID: 3778828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis.
    Hohlfeld T; Zimmermann N; Weber AA; Jessen G; Weber H; Schrör K; Höltje HD; Ebel R
    J Thromb Haemost; 2008 Jan; 6(1):166-73. PubMed ID: 17944992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of aspirin to impair bovine platelet function.
    Gentry PA; Tremblay RR; Ross ML
    Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.